🇺🇸 FDA
Patent

US 11786553

Chimeric cytokine receptors bearing a PD-1 ectodomain

granted A61KA61K2239/17A61K2239/23

Quick answer

US patent 11786553 (Chimeric cytokine receptors bearing a PD-1 ectodomain) held by Allogene Therapeutics, Inc. expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Allogene Therapeutics, Inc.
Grant date
Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61K, A61K2239/17, A61K2239/23, A61K38/00, A61K40/11